Jeffrey D. Abbey
2016
In 2016, Jeffrey D. Abbey earned a total compensation of $1.9M as President and Chief Executive Officer at Argos Therapeutics, a 35% increase compared to previous year.
Compensation breakdown
| Bonus | $356,500 |
|---|---|
| Option Awards | $1,029,892 |
| Salary | $450,000 |
| Other | $26,477 |
| Total | $1,862,869 |
Abbey received $1M in option awards, accounting for 55% of the total pay in 2016.
Abbey also received $356.5K in bonus, $450K in salary and $26.5K in other compensation.
Rankings
In 2016, Jeffrey D. Abbey's compensation ranked 5,210th out of 14,075 executives tracked by ExecPay. In other words, Abbey earned more than 63.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,210 out of 14,075 | 63rd |
Division Manufacturing | 1,871 out of 5,486 | 66th |
Major group Chemicals And Allied Products | 591 out of 1,900 | 69th |
Industry group Drugs | 441 out of 1,543 | 71st |
Industry Pharmaceutical Preparations | 351 out of 1,173 | 70th |
Source: SEC filing on July 6, 2017.
Abbey's colleagues
We found two more compensation records of executives who worked with Jeffrey D. Abbey at Argos Therapeutics in 2016.